Connection

Jian-Xing He to Surveys and Questionnaires

This is a "connection" page, showing publications Jian-Xing He has written about Surveys and Questionnaires.
Connection Strength

0.007
  1. Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer. Lung Cancer. 2018 08; 122:32-37.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.